Tumor Cell Nanovaccines Based on Genetically Engineered Antibody-Anchored Membrane.
Li Y, Zhang H, Wang R, Wang Y, Li R, Zhu M, Zhang X, Zhao Z, Wan Y, Zhuang J, Zhang H, Huang X.
Li Y, et al. Among authors: li r.
Adv Mater. 2023 Mar;35(13):e2208923. doi: 10.1002/adma.202208923. Epub 2023 Feb 15.
Adv Mater. 2023.
PMID: 36715052